Optogenetics extends well beyond neurons: light-sensitive proteins can control intracellular signaling pathways and cytoskeletal regulators like Rho-family GTPases, and they are used in developmental biology to study how a uniform ball of tissue becomes patterned into different body parts. Clinically, the clearest application discussed is restoring vision in people blinded by retinitis pigmentosa, a disease that destroys rods and cones, by inserting channelrhodopsin-like proteins into remaining eye cells so that special light-emitting glasses let a previously blind person detect and grasp objects. The hosts frame this alongside broader hopes that understanding brain circuits through optogenetics could eventually inform conditions like depression, anxiety, PTSD, Alzheimer's, dementia, and Parkinson's, though these are described as downstream possibilities rather than current treatments.
- 01
The vision-restoration work is described as being in clinical trials, not yet an established treatment.
- 02
Rho-family GTPases are identified specifically as cytoskeletal proteins that can make a cell move and contort.
- 03
The developmental biology use case is framed around the classic question of how a uniform tissue mass becomes spatially patterned, such as forming a head versus a tail.
461 words · auto-generated from the episode video
1:04:03associated with neuroscience, but it's got a much broader significance as we just showed. It's it can be used to talk about the heart. Light sensitive proteins can be engineered to regulate intracellular signaling pathways inside the cell. They can be used to control light sensitive systems like row family GTPs which are another set of cytokeleletal proteins that like can make the cell move and contort. In development biology, light sensitive tools can be used to investigate how, you know, spatially localized tissue becomes what they are as the animal grows up, right? You've got a ball of tissue. How does this node become the
1:04:45head and this become the tail? >> We talk about it all the time. >> We talk about that all the time. That's a that's a problem that can be used >> that optogenetics can be used for. So, it's it's huge, right? >> Yeah. >> And finally, um there is hope for new medical treatments. I mean beyond just the fundamentals of understanding how the brain works. Yeah. Right. That is going to clearly give us a better understanding about depression, anxiety, PTSD Alzheimer's dementia Parkinson's, you name it. Right. At the end of the day, understanding the brain at a fundamental level is going to give us insights into >> all of these name ailments, right? Because fundamental science, I think, happens first. But in a very direct
1:05:25sense, it's also used as the first step towards an optogenetics treatment for blindness. So there's ongoing clinical trials that are happening to restore vision in people who have become blind due to retinitis pigmentotosa. It's a disease that destroys the rods and cones. Here they've inter they've inserted channel redopsin-l like proteins into the eye of a blind person. Those neurons then express channel red rodopsin and now the person has regained some kind of vision. This is a paper that shows like special glasses that emit light into the person's eye and
1:06:06then that person is able to discern and grasp objects. someone who was you know previously blind. >> That's I mean again it it is both things are now concurrently happening which is the expansion of the basic and fundamental research across you know all of the areas of the human body not just the brain but we are in >> the tri clinical trial phase for applied you know >> uh clinical or medical outcomes that are impacting people's real lived experience. Yeah. >> Our eyesight is so such a core part of what we experience the world. If you
1:06:47have a very like effective way to restore that for people, um >> what's not to love? >> What's not to love, right? And when we predicted when we predicted